Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inadequate Glucose Control”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02099110
What this trial is testing

Ertugliflozin and Sitagliptin Co-administration Factorial Study (VERTIS FACTORAL, MK-8835-005)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 1,233
Testing effectiveness (Phase 2)Study completedNCT00792935
What this trial is testing

Test MK-0941 in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-0941-017)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 143
Large-scale testing (Phase 3)Study completedNCT00411554
What this trial is testing

Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Diet/Exercise Therapy (0431-054)(COMPLETED)

Who this might be right for
Diabetes Mellitus, Non-Insulin-Dependent
Merck Sharp & Dohme LLC 319
Large-scale testing (Phase 3)Study completedNCT00673231
What this trial is testing

Efficacy and Safety of Dapagliflozin, Added to Therapy of Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin

Who this might be right for
Type 2 Diabetes
AstraZeneca 1,240
Large-scale testing (Phase 3)Study completedNCT02421510
What this trial is testing

Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy

Who this might be right for
Type 1 Diabetes Mellitus
Lexicon Pharmaceuticals 782
Large-scale testing (Phase 3)Study completedNCT00701090
What this trial is testing

Test the Safety and Efficacy of Sitagliptin Compared to Glimepiride in Patients With Type 2 Diabetes on a Stable Dose of Metformin (0431-803)(COMPLETED)

Who this might be right for
Type 2 Diabetes Mellitus, Non Insulin DependentDiabetes Mellitus, Non-Insulin-Dependent
Merck Sharp & Dohme LLC 1,035
Post-approval studies (Phase 4)Study completedNCT00971997
What this trial is testing

Insulin Lispro Mix in Type 2 Diabetic Asian Patients

Who this might be right for
Diabetes Mellitus, Type 2
Eli Lilly and Company 135
Post-approval studies (Phase 4)Study completedNCT00377858
What this trial is testing

Comparison of Two Approaches to Insulin Therapy in Patients With Type 2 Diabetes (IOOX)

Who this might be right for
Diabetes Mellitus, Type 2
Eli Lilly and Company 484
Large-scale testing (Phase 3)Study completedNCT01210001
What this trial is testing

Efficacy and Safety of Empagliflozin (BI 10773) in Type 2 Diabetes Patients on a Background of Pioglitazone Alone or With Metformin

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 499
Large-scale testing (Phase 3)Study completedNCT00449930
What this trial is testing

Sitagliptin Comparative Study in Patients With Type 2 Diabetes (0431-049)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 1,050
Large-scale testing (Phase 3)Study completedNCT02794792
What this trial is testing

Assess the Efficacy and Safety of Ipragliflozin in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin

Who this might be right for
Type 2 Diabetes Mellitus
Astellas Pharma Europe B.V. 268
Large-scale testing (Phase 3)Study completedNCT00722371
What this trial is testing

MK0431 and Pioglitazone Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-102 AM2)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 1,615
Large-scale testing (Phase 3)Study completedNCT03332771
What this trial is testing

Efficacy and Safety of Sotagliflozin Versus Glimepiride and Placebo in Participants With Type 2 Diabetes Mellitus That Are Taking Metformin Monotherapy

Who this might be right for
Type 2 Diabetes Mellitus
Lexicon Pharmaceuticals 954
Large-scale testing (Phase 3)Ended earlyNCT03761134
What this trial is testing

Efficacy and Safety of Sotagliflozin Versus Placebo in Chinese Patients With Type 2 Diabetes Mellitus Not Adequately Controlled by Metformin With or Without Sulfonylurea

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 377
Large-scale testing (Phase 3)Study completedNCT02769481
What this trial is testing

Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes Subjects

Who this might be right for
Type 2 Diabetes Mellitus
Theracos 426
Post-approval studies (Phase 4)Study completedNCT01175811
What this trial is testing

A Study Comparing Insulin Intensification Therapies in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Eli Lilly and Company 402
Testing effectiveness (Phase 2)Study completedNCT00328172
What this trial is testing

Efficacy and Safety of 3 Doses of BI1356 (Linagliptin) in Type 2 Diabetes Patients

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 302
Large-scale testing (Phase 3)Study completedNCT03115112
What this trial is testing

Safety and Efficacy of Bexagliflozin Compared to Sitagliptin as Add-on Therapy to Metformin in Type 2 Diabetes Subjects

Who this might be right for
Type 2 Diabetes Mellitus
Theracos 386
Large-scale testing (Phase 3)Study completedNCT00859898
What this trial is testing

Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 1,093
Large-scale testing (Phase 3)Study completedNCT01106677
What this trial is testing

The CANTATA-D Trial (CANagliflozin Treatment and Trial Analysis - DPP-4 Inhibitor Comparator Trial)

Who this might be right for
Diabetes Mellitus, Type 2
Janssen Research & Development, LLC 1,284
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation